Pre-Market Gappers
Gapping Up:
IMCL +8.4% (co discloses that Icahn rejected a $36/sh offer from a major pharmaceutical co; IMCL uses this as an example why shareholders should reject Icahn's attempt to dislodge board members), OMG +6.8% (guides sharply higher), CTDC +18% (extends yesterday's 19% move), SKS +5.3% (declares $4/sh special dividend), BOBE +5% (Sept same store sales), ARNA +4.3% (Cramer bullish on Mad Money), WWW +4% (reports Q3 results; Matrix upgrade), MED +3.8% (CNBC stock picking champ Thomas Ko buying MED), LMIA +3.6% (announces Gulfstream contract), ARRS +3.2% (Cramer bullish on Mad Money), ONNN +2.9%, CCOI +2.8% (RBC upgrade), SIRI +2.2% (announces subscriber data), HGSI +1.8% (reports significant progress on commercialization), CBEY +1.8% (prices offering), VLO +1.5% (provides guidance), MRVL +1.2% (recovers a bit after yesterday's 12% sell off), GM +1.2% (amends governance policies; Bear Stearns upgrade), Under $3: AVAN +18% (signs deal with Pfizer).
IMCL +8.4% (co discloses that Icahn rejected a $36/sh offer from a major pharmaceutical co; IMCL uses this as an example why shareholders should reject Icahn's attempt to dislodge board members), OMG +6.8% (guides sharply higher), CTDC +18% (extends yesterday's 19% move), SKS +5.3% (declares $4/sh special dividend), BOBE +5% (Sept same store sales), ARNA +4.3% (Cramer bullish on Mad Money), WWW +4% (reports Q3 results; Matrix upgrade), MED +3.8% (CNBC stock picking champ Thomas Ko buying MED), LMIA +3.6% (announces Gulfstream contract), ARRS +3.2% (Cramer bullish on Mad Money), ONNN +2.9%, CCOI +2.8% (RBC upgrade), SIRI +2.2% (announces subscriber data), HGSI +1.8% (reports significant progress on commercialization), CBEY +1.8% (prices offering), VLO +1.5% (provides guidance), MRVL +1.2% (recovers a bit after yesterday's 12% sell off), GM +1.2% (amends governance policies; Bear Stearns upgrade), Under $3: AVAN +18% (signs deal with Pfizer).
0 Comments:
Post a Comment
<< Home